A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component
CA 2225412 C · Owner: Nakamura, Toyoo · Inventors: Kagawa, Kyoichi; Numata, Masahiro; Watanabe, Shigeaki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a peptide having the amino acid sequence shown in the sequence listing; an agent for inhibiting elevations of triglyceride levels in blood comprising the above peptide, a peptide Val-Tyr-Pro and/or a peptide Val-Thr-Leu as an active component; a food for specified health use which is endowed with a function of inhibiting elevations of triglyceride levels in blood by comprising these peptides as an active component; and a feed which is endowed with a function of inhibiting elevations of triglyceride levels in blood by comprising these peptides as an active component. According to the present invention it becomes possible to, prevent or treat obesity and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 23, 1995 and granted February 20, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 23, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 23, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.